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Abstract

In this scholarly project, the project leader implemented a chart audit and provider feedback
intervention with the aim of improving provider referrals for patients who screened positive for
depression—a risk factor in the myocardial infarction (MI) population—with the Patient Health
Questionnaire-9 (PHQ-9). The clinical question was developed in order to examine whether the
depression-screening tool that was implemented improved provider referrals to the in-house
licensed counselor or primary care physician after an educational feedback intervention, focusing
on physicians, nurse practitioners (NPs) and physician assistants (PAs). The target population
involved cardiology providers and adult patients who experienced a MI, including Non-ST
Segment Elevation Myocardial Infarctions (NSTEMIs) and ST Segment Elevation Myocardial
Infarctions (STEMIs). The project was an evidence-based practice (EBP) project using a quasiexperimental design for purposes of auditing charts and offering educational performance
feedback to the providers, with the aim of increasing referrals for patients, post-MI who screened
positive for depression. A retrospective chart audit was conducted for the analyses to assess the
number of referrals made for patients who screened positive for depression during scheduled
follow-up visits. The providers were given an aggregate performance report that specified the
findings of the group. The Two-Proportions Test and the Fisher’s Exact Test were applied, and
demonstrated no statistical improvement between the pre- and post-intervention data. This
project revealed significant clinical value to the practice setting. Provider knowledge,
perceptions, and attitudes must be assessed as well as the need to target the nursing population.
Keywords: depression, myocardial infarction (MI), referrals, chart audit, educational
feedback, Patient Health Questionnaire-9 (PHQ-9)
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Screening for Depression

The focus of this project was the need to address psychological factors, specifically
depression, in patients who have suffered a myocardial infarction (MI). One trigger that brought
this topic to the forefront is that failure to address psychological issues after a MI can lead to a
less successful recovery (American Psychological Association [APA], 2011). Individuals postMI are three times more likely to develop depressive symptoms compared to the overall
population; major depressive disorder occurs in nearly a quarter of these patients, with an even
greater percentage of patients experiencing increased levels of depression-like symptoms
(Lichtman et al., 2009; Williams, 2011). Screening for depression is vital and should be utilized
to identify patients, post-MI who may be at risk, as depression increases mortality and morbidity
(Lichtman et al., 2009); however, there is a gap in provider awareness and implementation in
depression screening (Blumenfield, Suojanen, & Weiss, 2012; Elderon, Smolderen, Na, &
Whooley, 2011; Lichtman et al., 2014; McGuire, Eastwood, Hays, Macabasco-O’Connell, &
Doering, 2014; Young, Nguyen, Roth, Broadberry, & Mackay, 2014). The aim of conducting
this project was to increase provider knowledge of post-MI depression and to assess whether
educational feedback increased the number of referrals made to the in-house licensed counselor
or primary care physician. Depression must be addressed in patients who have had MIs, assessed
as a risk factor, and treated accordingly to improve quality of life (American College of
Cardiology [ACC], 2016; Blumenfield et al., 2012; Davidson et al., 2010; Denollet, Martens,
Smith, & Burg, 2010; Dowlati, Herrmann, Swardfager, Reim, & Lanctôt, 2010; Elderon et al.,
2011; Lichtman et al., 2008; Lichtman et al., 2009; McGuire et al., 2014; Meijer et al., 2011; von
Känel & Begré, 2006; Young et al., 2014).
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Background

There is a strong body of science that supports the need for psychological factors to be
addressed in the post-MI population. Research has shown that identifying depression as a risk
factor in patients post-MI can help prevent the occurrence of subsequent cardiovascular events
(e.g., myocardial infarction, stroke, transient ischemic attack, heart failure, or death; Elderon et
al., 2011). The Joint Commission and the Centers for Medicare & Medicaid Services
collaboratively developed a specific set of core measures for hospitals and outpatient settings to
improve quality, minimize collection of data for the measurements, and concentrate on the
gathered data to improve the process of healthcare delivery (The Joint Commission, 2014).
Acute myocardial infarction is one area of focus that The Joint Commission established in its set
of core measures. Recently, the cardiovascular outpatient setting for which this project was
implemented established a process for screening patients, post-MI for psychological factors by
using the PHQ-9 and the Generalized Anxiety Disorder Questionnaire. Depression has been
associated with an increased recurrence of myocardial infarctions, stroke, transient ischemic
attacks, heart failure, and mortality, therefore, it is important to screen patients, post-MI to
ensure they receive proper treatment (Davidson et al., 2010; de Jonge, van den Brink,
Spijkerman, & Ormel, 2006; Elderon et al., 2011; Lichtman et al., 2008; Lichtman et al., 2009;
von Känel & Begré, 2006; Witters & Wood, 2015).
The project leader’s goal in working with the outpatient setting in this study was for
providers to understand the severity of depression in this at-risk population based on the required
and newly implemented depression-screening tool, in addition to making referrals appropriately
as outlined in the American Heart Association (AHA) guidelines. The AHA standards for
depression screening in the post-MI population recommend a two-step screening method
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involving the use of the PHQ-2 questionnaire followed by the PHQ-9 screening instrument, if
warranted (Lichtman et al., 2008). The PHQ-2 should be completed first, and if the response is
“yes” to one or both questions, then the individual needs to be referred for a more comprehensive
assessment, or should complete the PHQ-9 (Lichtman et al., 2008).
Purpose
The purpose of this project was to implement a chart audit and feedback intervention
aimed at improving the amount of referrals completed by providers for patients with a recent MI
who screened positive based on the depression-screening tool. Charts were audited for the
number of documented referrals in patients who screened positive for depression prior to the
educational intervention. During the performance feedback intervention, the providers were
educated on the established AHA guidelines, the link between depression and MIs, and the
importance of referring these individuals to the in-house licensed counselor or primary care
physician. After this educational intervention, the project leader conducted an additional review
of charts to evaluate if there was an increase in the number of referrals made within this subset of
patients.
The target population for this project were cardiology providers who conducted post-MI
post-hospitalization office visits. Provider education feedback included the importance of
referring patients who screened positive for depression in the adult MI population and included
provider referral performance. The goal of the feedback intervention was to see an increase in
referrals of patients post-MI who screened positive for depression on the PHQ-9 to the in-house
licensed counselor or primary care physician by educating cardiology providers on the
importance of screening for and treating depression in the post-MI population. Whether or not
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this goal was met was measured by a chart audit to determine if there was an increase in the
number of referrals made after the feedback intervention.
Clinical Question
Does a chart audit and provider feedback intervention improve the number of cardiology
provider referrals to the in-house counselor or primary care physician for patients post-MI who
have screened positive for depression?
Population: The target population was cardiology providers at an outpatient cardiology office in
Central Virginia.
Intervention: The primary intervention of this project was auditing charts and offering
educational performance feedback to the providers.
Comparison: Audited charts were compared prior to (control group) and after the educational
performance feedback intervention (comparison group).
Outcomes: The primary outcome was increasing the number of referrals made by cardiology
providers to the in-house licensed counselor or primary care physician for patients post-MI based
on their depression-screening tool (PHQ-9) results.
Literature Review and Synthesis
A comprehensive electronic database search was completed using EBSCOhost,
CINAHL, PubMed, MEDLINE, the Cochrane Library, SocINDEX, Health Source:
Nursing/Academic Edition, Health and Psychosocial Instruments, and Psychology and
Behavioral Sciences Collection. Search terms and phrases included depression, acute myocardial
infarction, chart audit, and feedback. Studies that were reviewed included randomized controlled
trials (RCTs), evidence-based clinical practice guidelines based on systematic reviews of RCTs,
observation studies, surveys, questionnaires, prospective cohort studies, longitudinal studies,
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meta-analysis reviews, placebo-controlled studies, and double-blind trials. The Levels of
Evidence (LOE) included: I, III, IV, V, VI, and VII. Literature was narrowed to include the
English language with full-text articles only, but no limitation was placed on publication dates.
AHA Recommendations for Management of Depression
The guideline entitled, Depression and coronary heart disease recommendations for
screening, referral, and treatment: A science advisory from the American Heart Association
Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical
Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality
of Care and Outcomes Research, was developed by the American Heart Association (AHA). The
objective of the AHA Science Advisory is to deliver rapid, transparent, and reliable standing on
scientific concerns, although an AHA advisory board must not be viewed as a treatment
guideline (Bigger & Glassman, 2010). All of the AHA statements go through a peer review
process and are approved by the AHA Science Advisory and Coordinating Committee, which is
AHA’s chief body of science (Bigger & Glassman, 2010). The American Heart Association
requested the American Psychological Association (APA) to review the proposed statement
because this specific advisory addressed the relationship between cardiac and psychological
health; the APA validated the AHA advisory (Bigger & Glassman, 2010).
AHA Recommendations for PHQ Screening
The AHA issued a scientific statement recommending routine screening, referral, and
treatment for patients with coronary heart disease and depression, applying a two-step
implementation of the Patient Health Questionnaire (PHQ), followed by a nine-step PHQ if
indicated (Lichtman et al., 2008). The Patient Health Questionnaire-2 (PHQ-2) inquires about the
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occurrence of depressed mood and anhedonia by asking the following questions: “Over the past
two weeks, how often have you been bothered by any of the following problems?
(1) Little interest or pleasure in doing things.
(2) Feeling down, depressed, or hopeless” (Lichtman et al., 2008, p. 1769).
The AHA recommends utilizing the PHQ-2, at a minimum, in order to distinguish the risk of
depression in patients. If the response is “yes” to either one of the questions, then referral is
warranted, in addition to screening all items of the Patient Health Questionnaire-9 (Bigger &
Glassman, 2010; Lichtman et al., 2008).
The PHQ-9 is a short tool to screen for depression (Lichtman et al., 2008), and includes
the following questions:
Over the past two weeks how often have you been bothered by any of the following
problems?
(1) Little interest or pleasure in doing things.
(2) Feeling down, depressed, or hopeless.
(3) Trouble falling asleep, staying asleep, or sleeping too much.
(4) Feeling tired or having little energy.
(5) Poor appetite or overeating.
(6) Feeling bad about yourself, feeling that you are a failure, or feeling that you have let
yourself or your family down.
(7) Trouble concentrating on things such as reading the newspaper or watching
television.
(8) Moving or speaking so slowly that other people could have noticed. Or being so
fidgety or restless that you have been moving around a lot more than usual.
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(9) Thinking that you would be better off dead or that you want to hurt yourself in some
way. (Lichtman et al., 2008, p. 1769; Appendix H)
The PHQ-2 and PHQ-9 offer healthcare providers brief, self-administered instruments for
evaluating depression (APA, 2016b). A result is generated based on the answers and added to
obtain a total score for depression severity (APA, 2016b). These questionnaires are commonly
used for screening and diagnosing depression as well as choosing and examining therapeutic
interventions (APA, 2016b). Reliability and validity of the screening tool have specified allencompassing dependable psychosocial properties (APA, 2016b). PHQ-9 scores (>10) have
demonstrated a sensitivity of 88% and specificity of 88% for depression (APA, 2016b). Internal
consistency has also been proven to be high and a study involving two different patient groups
produced Cronbach’s alphas of 0.86 and 0.89 (APA, 2016b).
The majority of individuals are able to finish the questionnaire in five minutes or less,
and the results include a temporary depression diagnosis and an intensity score that can be
applied in the selection of treatment options and further observation (Lichtman et al., 2008).
According to the AHA (2008), follow-up during a subsequent visit is advised for patients with
mild symptoms, but in patients with moderate to severe results, a healthcare provider must
review the answers with the patient. Overall, patients who score a high probability of depression
through the use of the questionnaire must be referred to a qualified professional for a more
comprehensive clinical evaluation to determine an appropriate personalized treatment
intervention (Lichtman et al., 2008). Patients who require a more inclusive clinical assessment
must be evaluated for the occurrence of other psychosocial conditions in order to avoid further
adverse outcomes (Lichtman et al., 2008).
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According to the AHA (2008), existing evidence signifies that only half of all cardiology
providers treat depression in their patients, and those patients who are identified as depressed are
not being treated. Some cardiology providers are hesitant to treat depression in patients after an
acute coronary episode because they consider depression a “normal” response in stressful life
events (Lichtman et al., 2008). In numerous instances, depression may occur prior to, or long
after an acute cardiac episode; therefore, it is imperative to evaluate depression in cardiac
patients with the objective of targeting those in need of therapeutic intervention and support
service industries (Lichtman et al., 2008).
Cardiologists should take depression into account in the management of CHD [coronary
heart disease], regardless of whether they treat the depression or refer the patient to a
healthcare provider who is qualified in the assessment and treatment of depression, which
often may be the patient’s primary care provider. (Lichtman et al., 2008, p. 1770)
Evidence Supporting the Link between MI and Depression
The literature reviewed on the topic of depression and cardiac patients established that
further assessment, referral, and treatment plans are needed in this specific population (ACC,
2016; de Jonge et al., 2006; Denollet et al., 2010; Elderon et al., 2011; Lichtman et al., 2014;
McGuire et al., 2014; Meijer et al., 2011; Witters & Wood, 2015). Depression outcomes can be
more severe in individuals with co-existing depression (ACC, 2016). Patients diagnosed with
depression have increased risks of MI and death compared to individuals who are not depressed
(ACC, 2016). Individuals with a current diagnosis of depression, who are also receiving
treatment, are at an even higher risk for symptoms to exacerbate after a heart attack (ACC, 2016;
Witters & Wood, 2015). Almost 40% of post-MI individuals have either major or minor
depression (von Känel & Begré, 2006). Individuals who have developed depression for the first
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time post-MI have been identified to be at the highest risk of suffering subsequent cardiac events
(von Känel & Begré, 2006).
Depression was not being addressed in patients with coronary artery disease or being
appropriately treated, according to some studies (ACC, 2016; Dowlati et al., 2010; McGuire et
al., 2014; Meijer et al., 2011; von Känel & Begré, 2006; Witters & Wood, 2015). Healthcare
providers must know the importance of assessing depression as a risk factor and referring
patients to a psychologist, licensed counselor, or primary care physician for further evaluation
and management. The majority of the studies indicated that depression is frequently not assessed
and often left untreated (ACC, 2016; de Jonge et al., 2006; Dowlati et al., 2010; Elderon et al.,
2011; Lichtman et al., 2009; McGuire et al., 2014; Meijer et al., 2011; von Känel & Begré,
2006). Evidence supports that providers need to identify depression as a risk factor in the postMI population, and depression must be identified as a potential sign of further cardiac events
(e.g., myocardial infarction, stroke, transient ischemic attack, heart failure, or death; Davidson et
al., 2010; Elderon et al., 2011; Hosseini et al., 2011; Lichtman et al., 2009; Young et al., 2014).
Utilizing depression screening tools was recommended in 13 out of the 18 articles on the
topic of depression and coronary heart disease (ACC, 2016; Bigger & Glassman, 2010;
Blumenfield et al., 2012; Davidson et al., 2010; de Jonge et al., 2006; Denollet et al., 2010;
Elderon et al., 2011; Lichtman et al., 2008; Lichtman et al., 2009; Lichtman et al., 2014;
McGuire et al., 2014; Williams, 2011; Young et al., 2014). Screening patients for depression is
imperative because depression is a risk factor for further myocardial infarctions, severe angina,
stroke, transient ischemic attack, heart failure, or death (ACC, 2016; Elderon et al., 2011;
Lichtman et al., 2008). Screening must be done at routine interims of time to prevent missed
opportunities to intervene (ACC, 2016). Regularly screening patients with coronary heart disease
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for depressive symptoms was recommended in the outpatient setting for this project to ensure
that proper follow-up on psychological factors was taking place (Davidson et al., 2010; Lichtman
et al., 2009; Meijer et al., 2011; Young et al., 2014).
Evidence Suggesting Identifying and Treating Depression post-MI Improves Outcomes
Once depression symptoms have been identified and treated in patients with coronary
heart disease, the rate of mortality and reoccurrence of cardiac events declines (Denollet et al.,
2010; Dowlati et al., 2010; Lichtman et al., 2014; Meijer et al., 2011). Furthermore, the literature
signified that if signs of depression were left untreated or unidentified, the risk of cardiac events
increased, as did the rate of mortality (Blumenfield et al., 2012; Davidson et al., 2010; Denollet
et al., 2010; Meijer et al., 2011). Psychological factors have been linked to a less favorable
outcome and a poorer prognosis in patients with myocardial infarctions. According to de Jonge
et al., it is important to implement a more individually devised treatment plan for each patient (as
cited in von Känel & Begré, 2006). Due to the multitude of factors contributing to post-MI
depression, it is presumed to be both biological and psychosocial in nature (von Känel & Begré,
2006). Based on the evidence and review of literature, the project leader’s main objectives in
regard to the cardiology providers treating individuals, post-MI, were to increase awareness and
screening for depression, to review the PHQ-9 results completed by the patients, and to increase
the number of referrals made.
Chart Audit and Provider Feedback to Improve Outcomes
Evidence within the literature demonstrates the significance chart audit and provider
feedback systems have within organizations. An audit and feedback intervention is one of the
most widely implemented strategies for reducing gaps within healthcare, improving professional
practice, and refining quality improvement interventions (Colquhoun et al., 2013; Ivers et al.,
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2012). The project leader believed that an audit and feedback intervention would alert healthcare
professionals to change their current practice routine when provided with educational feedback
displaying inconsistency of their current practice with an appropriate objective (Ivers et al.,
2012). The phrase “Audit and Feedback” (A&F) has been commonly used to indicate a various
collection of interventions that provide feedback to healthcare providers on current practice
(Colquhoun et al., 2013). A&F can be described as a synthesis of clinical performance (audit)
over a specified timeframe, and the delivery of that synthesis (feedback) to specific healthcare
providers, practitioners, teams, or organizations (Colquhoun et al., 2013). Numerous studies have
been conducted using the A&F method and include randomized-controlled trials (RCT), nonRCT designs, systematic evaluations, and meta-analysis reviews (Brehaut et al., 2016;
Colquhoun et al., 2013; Ivers et al., 2012; O’Rourke, Fraser, Boström, Baylon, & Sales, 2013).
The review of literature was extensive and identified the AHA guidelines for depression
management through the utilization of the PHQ screening developed by Drs. Kroenke, Spitzer,
Williams (2001) and colleagues in the mid-1990’s (Lichtman et al., 2008). As described above,
there was clear evidence supporting the correlation between MI and depression (ACC, 2016; de
Jonge et al., 2006; Denollet et al., 2010; Elderon et al., 2011; Lichtman et al., 2014; McGuire et
al., 2014; Meijer et al., 2011; Witters & Wood, 2015). The evidence revealed that proper
identification and treatment of post-MI depression improves outcomes in patient health
(Blumenfield et al., 2012; Davidson et al., 2010; Denollet et al., 2010; Dowlati et al., 2010;
Lichtman et al., 2014; Meijer et al., 2011; von Känel & Begré, 2006). The review of literature
indicates quality advances in healthcare and provider practice when chart audits and provider
feedback interventions are implemented (Brehaut et al., 2016; Colquhoun et al., 2013; Ivers et
al., 2012; O’Rourke et al., 2013).
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Conceptual Framework

The Iowa Model of Evidence-Based Practice to Promote Excellence in Health Care was
used as the conceptual framework for the anticipated practice change in this study. It is
composed of combined evidence-based practice (EBP) directed toward clinical practice settings
in order to advance quality care and outcomes. A conceptual framework can be compared to a
map because it demonstrates the joining of key elements with that of the scholarly project
(Moran, 2014). The steps involved in the model include choosing a topic by identifying triggers,
creating a team, obtaining evidence, ranking the evidence, designing and piloting the practice
change, implementing the project, integrating and sustaining the practice change, and
disseminating the findings (see Appendix G for permission from University of Iowa Hospitals to
use this model). The Iowa Model was the most applicable model to lead this scholarly project
because its main objective is to serve as a guide for healthcare providers, and it utilizes evidencebased findings for improvement of care (Titler et al., 2001).
After obtaining the required approvals from the Project Chair, committee members,
primary institute’s Institutional Review Board (IRB), project organization’s IRB, and the
Medical Director where the project was implemented, the project leader piloted the audit and
educational feedback interventions in accordance with the Iowa Model of EBP. During the
implementation phase of the project, a pre-intervention chart audit of the electronic medical
record (EMR) was conducted retrospectively within the specified timeframe, followed by
analysis of the collected data. The next step during the implementation process was
administering the educational feedback session to the cardiology providers. A post-intervention
EMR chart audit was subsequently conducted after the 30-day timeframe in order to re-assess
performance data and analyze the results. During the evaluation process of the project the project
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leader determined whether the evidence-based chart audit, provider performance feedback, and
educational intervention led to an increased number of referrals made by providers for patients
who screened positive for depression post-MI. In order to offer incentive, provider performance
feedback was administered after the second chart audit was concluded to further increase
screening and referrals made for patients, as recommended by the AHA guidelines.
In alignment with the Iowa Model, the project leader identified a knowledge-focused
trigger to evaluate clinical efficacy. It was also determined that the selected topic was viewed as
a priority for the outpatient office due to their recent implementation of a new protocol for
depression screening in the post-MI population, which included the PHQ-9 screening instrument
and the Generalized Anxiety Disorder Item-7 Assessment. The third step involved the formation
of a team responsible for the advancement, implementation, and assessment of the EBP project
(Titler et al., 2001). The project leader gathered, synthesized, and evaluated relevant literature
studies in accordance with the Iowa Model of EBP. The final step that was completed included
monitoring and examining the structure, development, and measurable outcomes of the EBP.
The project leader verbally presented the scholarly project proposal to the Project Chair and
committee members, who provided feedback and requested modifications as needed for the
purpose of improving the project. Once the chair and committee approved the proposal, pre- and
post-intervention chart audits for increased referrals within the target population were conducted
and compared with the verbal and written educational feedback presented to the cardiology
providers.
The Iowa Model recommends extensive literature reviews, which allows researchers to
find problem-focused triggers that question the existing practice and inquire whether patient care
could be enhanced by utilizing the findings and outcomes reached (Clanton, 2014). There are
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multiple evidence-based studies and systematic reviews indicating the risk that depression poses
to individuals post-MI and the need for referrals (ACC, 2016; APA, 2016a; Bigger & Glassman,
2010; Davidson et al., 2010; de Jonge et al., 2006; Dowlati et al., 2010; Elderon et al., 2011;
Hosseini et al., 2011; Lichtman et al., 2008; Lichtman et al., 2009; Lichtman et al., 2014;
McGuire et al., 2014; Meijer et al., 2011; von Känel & Begré, 2006; Witters & Wood, 2015;
Williams, 2011; Young et al., 2014). Uniformity was found throughout critiquing the literature
of common results as well as diversity among the various studies conducted. The utilization of
the Iowa Model successfully supported this evidence-based scholarly project. After the project
was implemented, it was assessed that no improvement in practice change occurred; therefore it
is necessary to continue to evaluate quality of care and new knowledge. The results of this
project showed that there was no improvement in practice change for the providers who attended
the educational intervention, which indicates that it is necessary to continue to evaluate quality of
care and implement new knowledge that can enhance best practices.
Design, Methodology, and Statistical Analysis
The design for this evidence-based practice project was a quasi-experimental approach to
collect and analyze data, using a one-group pretest/posttest strategy. This type of design allowed
the project leader and personnel to evaluate the effects of chart auditing and assess the
educational feedback intervention presented to the cardiology providers. The outpatient
cardiology office recently implemented a depression-screening instrument (the PHQ-9 and
Generalized Anxiety Disorder Item-7 Assessment) for providers to screen every patient during
follow-up visits, post-hospitalization. Consistent with established guidelines, studies have
revealed that follow-up visits decrease mortality during hospitalization and at the six-month postdischarge period (Cubbon et al., 2007; Mercado, Smith, & McConnon, 2013; Peterson et al.,
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2006). Therapeutic treatment plans, including medications, have been shown to decrease
mortality at six months, which is why this timeframe would have been utilized during the preintervention chart auditing if the recently executed screening tools had not been implemented
within the outpatient setting (Mercado et al., 2013). Ideally, the period to include the post-MI
population (pre-intervention) in this study would have been within a six-month span due to
evidence-based standards that were established in previous studies (Cubbon et al., 2007;
Mercado et al., 2013; Peterson et al., 2006). As a result of the unforeseen implementation of the
depression screening tools, the timeframe for the pre-intervention chart audit for this project had
to commence on January 3, 2017 (the first day the screening instruments were initiated).
The dependent variable in this project was whether there was documentation that
providers were referring patients who screened positive for depression based on the results from
the PHQ-9, by allocating a specific number (0 = N/A; 1 = unmet; 2 = met). Zero signified that
the patient was screened but did not meet the requirements for referral based on the AHA
guidelines. Number 1 indicated that the patient was not appropriately referred when warranted,
or if the PHQ-9 was not even administered to the patient; therefore, not having the ability to
identify whether the he or she needed to be referred since no opportunity was given to complete
the screening tool.
In order to compare the pre- and post-intervention dependent variables, a nonparametric
inferential statistical analysis was utilized. Nonparametric methods do not make inferences about
the sample of the population division, which was one of the reasons this type of method was
selected. Another reason a nonparametric inferential statistical analysis was appropriate for this
project is due to the smaller sample size gathered and the data that were divided into specific
categories, as previously described. The Fisher’s Exact Test was used to compare the pre- and
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post-intervention in order to assess the cardiology provider’s utilization of the aggregate
performance report. The Two-Proportions Test was applied when comparing the pre- and postintervention usage of the PHQ-9 screening tool among the providers. Both tests were
implemented to assess and measure success of the practice change.
Measurable Objectives
Measurable objectives included an increase in the number of documented referrals made
by providers to the in-house licensed counselor or primary care physician, for patients post-MI
who screened positive for depression. This was assessed after the educational feedback
intervention was completed. The providers were offered additional feedback after the second
chart audit was conducted. Measurable objectives were collected and analyzed during the preand post-intervention periods. The goal was for providers to be more aware of the serious risks
depression can pose in the post-MI population and to increase the number of referrals made in
patients who have screened positive for depression.
Sample and Setting
The setting for this project was an outpatient cardiology office in Central Virginia. It is a
national benchmark organization for cardiovascular care and committed to the prevention,
diagnosis, and management of heart and vascular disorders. The office is comprised of
cardiologists, advanced practice providers (nurse practitioners and physician assistants),
cardiothoracic surgeons, pharmacists, and a full-time staff of nurses, medical assistants, and
certified technicians. The outpatient clinic is open Monday-Friday, 8:00 a.m. to 5:00 p.m. with a
healthcare provider on-call twenty-four hours a day, seven days a week. The proposed project
was presented to the Medical Director of the outpatient office and the project leader obtained a
letter of support to conduct the study (Appendix D).
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The sample population consisted of two groups: (a) cardiology providers
(Physicians/NPs/PAs) and (b) adult patients post-MI, comprising Non-ST Segment Elevation
Myocardial Infarctions (NSTEMIs) and ST Segment Elevation Myocardial Infarctions
(STEMIs). The outpatient cardiology office consisted of physicians, nurse practitioners, and
physician assistants, equaling a total of 50 providers (N = 50). Approximately 15 patients are
seen each day for cardiology visits (scheduled follow-ups, post-hospital care appointments,
episodic add-ons, and first-time office visits).
The inclusion criteria for the primary sample population (aggregate performance of
cardiology providers) consisted of physicians, nurse practitioners, and physician assistants within
the outpatient cardiology clinic. The exclusion criteria included (a) non-cardiac providers (i.e.,
RNs, licensed practical nurses, laboratory assistants, and diagnostic technicians), (b) pediatric
cardiologists, (c) cardiothoracic surgeons, (d) subspecialty clinical providers (congestive heart
failure clinic and arrhythmia clinic), and (e) the Project Chair and practicum site preceptor.
The inclusion criteria for the secondary sample population (adult patients post-MI:
STEMIs and NSTEMIs) involved (a) individuals post-MI, post-hospitalization, (b) follow-up
office visits with a cardiology provider within the specified timeframe (from January 3, 2017 to
March 23, 2017), (c) diagnosis of MI (ICD-10 Code I21.01, I21.02, I21.09, I21.11, I21.19,
I21.21, I21.29, I21.3, I21.4, I22.0, I22.1, I22.2, I22.8, and I22.9), and (d) age ≥ 18 years old. The
exclusion criteria for the secondary sample population included (a) individuals who did not have
an MI, (b) individuals post-MI prior to January 3, 2017, and (c) age < 18 years old.
The outpatient cardiology center developed a post-MI transition clinic, called the H2O
(Hospital to Office) clinic. The H2O clinic was created in April 2016, specifically for patients
post-MI after hospitalization. Individuals being discharged from the hospital are scheduled
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within seven to ten days for follow-up with a cardiology provider, primary care physician (PCP),
or have an appointment with the H2O clinic. The purposes of the clinic are to follow-up
promptly with a Registered Nurse (RN), to reconcile medications to the office’s EMR, to
confirm follow-up appointments, to triage potential issues, and to decrease hospital readmission
rates. During this one-time visit, the RN assesses vital signs, verifies the prescribed medications,
educates the patient on the topic of diet, exercise, smoking cessation, cardiac rehabilitation, and
addresses any complications or concerns. The project leader considered the H2O clinic as a
means to inform the providers of the opportunities the H2O clinic offers in screening for
depression and increasing the number of referrals made.
Ethical Considerations
The project leader and committee have completed the Collaborative Institutional Training
Initiative (CITI; Appendix I). The final committee-approved project protocol was submitted to
the primary institute Institutional Review Board (IRB; Appendix E). Based on the final approval
from primary institute IRB, the protocol was submitted to the IRB within the cardiology
outpatient’s health care system (Appendix F). The project leader was in charge of selecting
which charts to include and exclude by confirming the identification of MI documentation (ICD10 Code I21.01, I21.02, I21.09, I21.11, I21.19, I21.21, I21.29, I21.3, I21.4, I22.0, I22.1, I22.2,
I22.8, and I22.9) within the specified timeframe, while maintaining the parameters for
inclusion/exclusion criteria as specified above. The project leader created three databases from
Excel and converted them to a password-secured PDF file in order to remain compliant with the
standards set forth by the Health Insurance Portability and Accountability Act (HIPAA). The
three databases included a Referral for Screening Depression in the MI Population Chart Audit
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Template (Appendix B), an Aggregate Educational Feedback Report Template (Appendix C),
and a Provider and Chart Identification Template (Appendix A).
The project leader will preserve the three main databases in a password-secured computer
for three years after the conclusion of the project. No duplicates will be made of these records.
After three years, the material will be erased from the computer in compliance with the standards
enacted. The project leader audited specific charts for the number of referrals made for patients
who screened positive for depression based on the PHQ-9 results (Appendix B). The data were
gathered, documented, and analyzed using the Statistical Package for the Social Sciences (SPSS)
database. Data documentation on the Referral for Screening Depression in the MI Population
Chart Audit Template, the Aggregate Educational Feedback Report Template, and the Provider
and Chart Identification Template were de-identified of patient and provider information. There
were no patient or provider identifying material connected with any presentations, posters, or
publications of the project. The providers can be assured of confidentiality, but not anonymity.
Intervention, Tool, and Data Collection
A baseline (pre-intervention) internal chart audit of the EMR system, known as
Centricity, was conducted to evaluate the number of referrals made by providers for individuals
who screened positive for depression in the MI population. During chart reviews, the following
items were assessed: utilization of the PHQ-9 screening instrument, outcome of the PHQ-9
screening tool, and referral(s) made to the in-house licensed counselor or primary care physician
based on the outcome of the PHQ-9 (Appendices A, B, & C). A pre-intervention chart audit was
conducted starting January 3, 2017 through March 23, 2017. As previously described, a sixmonth timeframe would have been ideal for the retrospective period, but due to the unanticipated
implementation of the depression screening tool, the period to conduct the pre-intervention chart
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audit needed to begin January 3, 2017 (the first day the screening tool was initiated). A 30-day
internal EMR chart audit was applied for the post-intervention analysis. An aggregate approach
was utilized due to the fact that during follow-up visits some cardiology providers assess more
individuals after an MI compared to other providers. The cardiology providers were given a
verbal and printed report that specified their performance as a group. The project leader
administered this aggregate performance report (pre-intervention) to the providers during a
scheduled team meeting.
A nonrandom purposive sampling method was indicated for the primary sample
population because this study specifically included cardiology providers that assess patients on
post-MI follow-up visits, excluding providers who are a part of the Arrhythmia and CHF clinics.
A systematic sampling technique, which is a type of probability sampling method, was selected
for the chart review aspect because it allowed the audited charts to be chosen in an evenly
distributed interval. The approach was strictly aggregate due to certain providers evaluating more
patients who have experienced MIs compared to others. The sample size included charts
collected from the cardiology providers to obtain an adequate amount of data. Provider feedback
was administered after the second chart audit was conducted in order to offer incentive to further
increase screening and referrals recommended by the established AHA guidelines.
The project leader delivered information on provider utilization of referrals based on the
depression-screening tool during the educational feedback intervention, as well as on the postintervention chart audit (Appendix B). Reliability and validity of the depression-screening tool
(PHQ-9 and PHQ-2) have strong support for symptoms of depression (APA, 2016b). The AHA
has published a scientific statement endorsing routine screening, referral, and treatment for
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patients, post-MI, who show signs of depression after applying a two-step implementation of the
PHQ (Lichtman et al., 2008).
Feasibility Analysis
The feasibility analysis included resources, personnel, technology, budget, and
cost/benefit analysis. The planned location had a designed structure already set in place that was
conducive to the project leader’s plan for collecting data. The project leader obtained approval
and support of major participants and team members prior to beginning the project.
Personnel
The following is a list of the personnel who played a role in either conducting or
participating in this project:
•

Project leader

•

Project Chair

•

Committee members

•

Nursing staff and office administrative support

•

Key stakeholders (physicians/NPs/PAs)

•

Information technology workers

Resources and Equipment
The following resources and equipment were necessary in order to complete the project:
•

Computer

•

Electronic Medical Record

•

Excel

•

SPSS

•

Aggregate Educational Feedback Report Template
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Referrals for Screening Depression in the MI Population EMR Audit Template

•

Provider and Chart Identification Template
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Cost/Benefit Analysis
The cost/benefit analysis remained budget neutral. The cost/benefit comparison can be
viewed as acceptable due to the fact that early recognition of depression greatly reduces the risk
of further cardiac events, morbidity, and hospital readmission rates. Additionally, the American
Heart Association Science Advisory, American College of Cardiology, and other expert
professional organizations have linked early recognition of depressive-like symptoms within this
population with more successful recoveries, and improved outcomes and quality of life. There is
strong evidence supporting healthcare providers to assess, to refer, and to treat depression in
patients post-MI (ACC, 2016; Lichtman et al., 2008). The potential benefit greatly outweighs the
risks through improved screening for depression in the post-MI population with an obvious
reduction in morbidity, mortality, and hospital readmission rates (ACC, 2016; de Jonge et al.,
2006; Denollet et al., 2010; Elderon et al., 2011; Lichtman et al., 2014; McGuire et al., 2014;
Meijer et al., 2011; Witters & Wood, 2015).
Timeline of Project Stages
Preparation. In accordance with the Iowa Model of EBP to Promote Excellence in
Health Care, the following steps were achieved: (a) problem-focused trigger was identified, (b)
team was created, (c) evidence was obtained and ranked, (d) practice change was piloted, (e)
project was implemented, (f) practice change was integrated and sustained, and (g) findings were
disseminated (see Appendix G for permission from University of Iowa Hospitals to use the Iowa
Model). The steps that occurred during the preparation stage included all of the following:
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By September 26, 2016, a team was formed that included the Scholarly Project
Committee Chair and two subsequent Scholarly Project Committee Members.

•

On October 17, 2016, the project proposal was presented to the Medical Director of
the cardiology outpatient clinic and approval was obtained.

•

On October 19, 2016, the proposal was reported to the committee with feedback and
questions answered following the Power Point presentation. All members of the
committee signed the Approval of the Scholarly Project Form along with the final
authorization made by the Project Chair.

•

On October 23, 2016, the proposal was submitted to Liberty University’s (LU’s)
Institutional Review Board (IRB).

•

By November 30, 2016, approval was received from LU’s IRB.

•

On December 1, 2016, the approved LU IRB documentation and proposal was
submitted to the IRB located within the cardiology outpatient’s health care system.

•

By January 9, 2017, outpatient health care system’s IRB approved the proposal
through their Exempt Committee with signatures obtained on the Exempt Status
Form.

Implementation. The audit and feedback intervention for practice change was designed
and piloted in accordance with the Iowa Model of EBP. The steps that occurred during this
timeframe included the following:
•

On March 23, 2017, pre-intervention internal chart audit of the EMR was conducted
retrospectively (January 3, 2017-March 23, 2017).

•

By April 3, 2017, pre-intervention data analysis began.

•

By April 5, 2017, pre-intervention data analysis was complete.
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On April 24, 2017, performance feedback intervention was provided to the cardiology
physicians.

•

On April 27, 2017, performance feedback intervention was provided to the cardiology
advanced practice providers (NPs and PAs).

•

By June 29, 2017, the post-intervention EMR internal chart audit was conducted
retrospectively (30-day timeframe: May 1, 2017-June 1, 2017).

•

By July 6, 2017, the post-intervention measurement was completed (re-assessed
performance data and analyzed results).

Evaluation. In accordance with the Iowa Model of EBP, the audit and feedback
intervention for practice change was evaluated and determined as to whether the chart audit,
provider feedback, and educational intervention led to an increased number of referrals made by
providers for patients who had screened positive for depression in the post-MI population. The
steps that occurred during this phase included the following:
•

By June 29, 2017, the post-intervention chart audit was conducted.

•

By July 6, 2017, the post-intervention internal chart audit data were investigated and
analyzed.

•

By August 2, 2017, the project outcomes and objectives were completed.

•

By August 4, 2017, the written scholarly project was disseminated to the Chair.

•

By August 17, 2017, the Chair-approved written scholarly project was disseminated
to the other committee members with feedback and answers concluded.
Evaluation/Analysis

The anticipated outcome of this project was for cardiology providers to demonstrate an
increased number of referrals for patients who screened positive for depression in the post-MI
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population after using the required depression-screening tool (PHQ-9). Including depression as a
risk factor in patients who have experienced an MI would have a significant influence on
patients’ recovery rates, quality of life, and wellbeing. With this intervention (chart audit and
educational feedback), providers were afforded the opportunity to increase the number of
referrals made based on the AHA recommended guidelines as a standard of care within the
practice setting.
Cardiology Provider Educational Feedback Intervention
An educational feedback intervention was prepared for the cardiology physicians and
advanced practice providers (APPs) after analyzing the pre-intervention data. A PowerPoint
presentation was delivered to the cardiologists and APPs along with an evidence-based
educational handout. The information offered at the provider meeting contained the following:
•

purpose of the scholarly project,

•

timeframe the project was conducted,

•

inclusion and exclusion criteria for the primary and secondary sample population,

•

established standards and guidelines set forth by the American Heart Association,

•

evidence supporting the link between MI, depression, and future cardiovascular
events,

•

statistics calculated in the outpatient practice from the pre-intervention chart audit,
and

•

objectives for the providers to pursue and to achieve (i.e. increase awareness and
screening for depression, review the PHQ-9 results, and increase the number of
referrals when indicated).
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Results

According to the AHA guideline and algorithm Screening for Depression in Patients with
Coronary Heart Disease, if patients score 10 points or greater out of 27 points on the PHQ-9
screening tool, they should be referred for additional clinical assessment by a qualified
professional to evaluate and establish an appropriate individualized treatment plan (Lichtman et
al., 2008). A total of 49 charts (n = 49) were collected during the pre-intervention (baseline)
chart audit, based on the inclusion and exclusion criteria previously discussed. Evaluation of this
set of data points revealed that screening had been documented in 32 of the audited charts,
representing that 65% had been screened appropriately through the use of the PHQ-9. This chart
audit revealed that depression screening had not been documented on 17 patients, demonstrating
that 35% had no documentation that the PHQ-9 was being used to screen patients for depression.
Of those 32 charts, 27 showed no indication that a referral was needed, signifying that 84% had
been screened but did not meet the criteria for referral (less than 10 points on the PHQ-9). Out of
those 32 charts that documented PHQ-9 screening, five qualified for referrals, indicating that
16% met referral criteria based on the AHA guidelines. Documentation revealed that three of
those five charts did receive a referral, but in two of the five charts, no referral was documented.
The data from the chart audit revealed that there was a lack of information about whether certain
patients (35%) needed to be referred because there was no documentation that screening had
been done.
In order to evaluate whether to evaluate whether the educational feedback intervention
produced a significant change in clinical practice, the project leader conducted a postintervention chart review to audit the number of referrals made by providers. Overall, 49 charts
(n = 49) were collected during the post-intervention chart audit, after the 30-day retrospective
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timeframe (May 1, 2017 to June 1, 2017). Out of the total 49 charts, it was documented that 31
patients (or 63%) were appropriately screened using the PHQ-9. The post-intervention chart
audit demonstrated that depression screening had not been documented on 18 patients, revealing
that 37% of charts showed no documentation of the PHQ-9 being administered. There were a
total of 26 patient charts that documented appropriate screening and that showed the patients did
not meet referral qualifications (less than 10 points on the PHQ-9), indicating that 84% of
patients who had been screened did not meet criteria for referral. Out of the 31 charts audited that
documented PHQ-9 screening, five individuals (16%) met criteria for referral based on the AHA
guidelines. Documentation showed that three out of the five patients were referred to the inhouse counselor and two had no documentation that a referral had been made, indicating that the
increase in referrals from pre- to post-intervention did not change. From a statistical point of
view, the PHQ-9 was used 32 out of 49 times in the pre-intervention group and 31 out of 49
times in the post-intervention group, which shows a slight decrease in the usage of the screening
instrument.
Both the pre-intervention and post-intervention data were collected and examined using
SPSS, by applying the Two-Proportions Test and the Fisher’s Exact Test. There was no
statistically significant difference between the pre- and post-intervention data. The Fisher’s Exact
Test was used to assess the correlation, interaction, and comparison between the pre- and postintervention data to evaluate if provider referrals increased after the educational feedback
session. Of those providers who documented the use of the PHQ-9 screening instrument, met the
AHA’s criteria, and made a referral based on the results, the p value was 0.738, with the
alternative hypothesis of p2 > p1. Based on this information, there was no evidence that the
percentage of referrals had increased after the educational feedback intervention.
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The Two-Proportions Test compared the percentages of the pre- and post-intervention
population to assess whether there was improvement in the usage of the PHQ-9. There was no
indication that the utilization of the PHQ-9 screening tool had increased after conducting the
educational feedback intervention. Comparing the pre- and post-intervention usage of the PHQ-9
screening instrument, using the Two-Proportions Test, the p value was 0.584, with the alternative
hypothesis of p2 > p1. These statistics indicated that there was no evidence that the application of
the depression-screening instrument was affected by the feedback intervention.
After the second chart audit, the project leader gave feedback to the providers of the
outpatient cardiology practice in an effort to motivate them to adopt the previously discussed
objectives using the AHA guidelines on depression screening. Despite the fact that there was no
difference between the pre- and post-intervention data collected from a statistical perspective,
this project still holds significant clinical value to the practice setting due to the specific link
between depression and MIs. The ultimate goal is to encourage practice change. Various
unforeseen factors existed throughout each phase of the project. In the subsequent paragraphs,
limitations of the project are considered and recommendations regarding how to make
improvements for future implementation and adoption of the practice change are addressed.
Project Limitations
Limitations to the scholarly project included the following: (a) timing of the project
within the outpatient setting, (b) number of charts collected during the pre- and post-intervention
timeframe, (c) omitted or limited documentation in the post-MI follow-up clinic notes, (d)
misplaced charts, (e) unreported information, (f) deviation of referrals in the correct location, (g)
incomplete retrieval of research, (h) lack of attention and engagement of providers, and (i)
multiple changes within the practice setting during the pre- and post-intervention. Another
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limitation was the fact that the project focused solely on patients, post-MI. This same type of
project has the potential to be applicable and beneficial to the remainder of the cardiovascular
population within the outpatient setting. Risk of bias and time constraints on the part of the
project leader were other possible limitations.
In regard to choosing a nonrandom purposive sampling technique, limitations included an
unspecified proportion and lack of representation of the total population (Dudovskiy, 2016).
There could also have been a reduced equivalent of generalization of outcomes in comparison to
probability sampling (Dudovskiy, 2016). With a nonrandom purposive sampling method, there
are potential problems in assessing sampling variability and recognizing potential bias
(Dudovskiy, 2016). Certain patients within the sample population (based on the inclusion and
exclusion criteria) could have been incorporated but may have been overlooked during the
process of auditing charts.
Two separate meetings were conducted for the cardiology providers, which could be
viewed as a limitation, even though it was still an aggregate approach. At least two of the
planned meetings were cancelled and shifted to later dates due to various reasons and unforeseen
circumstances within the practice setting. The first meeting was exclusively cardiologists and
took place at the beginning of the week. The second meeting occurred within the same week, but
three days later, and contained APPs only. Both groups did receive the same Power Point
presentation and evidence-based educational handout in order to maintain consistency.
Several of these unanticipated issues could have been avoided in a variety of ways. In
order to make advancement for future practice, the following tactics are recommended in order
to improve the pre/post-intervention data collection, educational performance feedback session,
and continued follow-up: (a) selecting a better timeframe in which to conduct the educational
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feedback session in order to increase engagement, attention, and adoption; (b) having the ability
to incorporate a question and feedback session within the educational performance intervention;
(c) merging other practice changes together to improve adoption and compliance among
providers; (d) following up and maintaining consistency in smaller group settings (or one-onone) to enhance engagement and adoption of the practice changes; (e) having additional
educational feedback discussions; (f) administering evaluations to the providers to assess their
knowledge prior to and after the interventions; (g) assessing provider perceptions and attitudes in
regard to this topic; and (h) evaluating whether the information reviewed aided the providers and
in what areas certain improvements or advances could be made. Another recommendation
involves delivering more effective techniques in discussing the priority of screening for
depression in the MI population as well as emphasizing its cost-effectiveness within the
outpatient setting. Future research must be done in regard to these recommendations as well as
assessing the hospital re-admission rates in this specific group of patients. Each one of these
suggestions should be addressed to improve engagement among providers and adoption of the
practice change for future application. These recommendations will assist in raising provider
awareness and screening for depression as well as increasing the number of referrals made based
on the AHA guidelines. The ultimate goal is to improve outcomes and quality of life for each
patient cared for within the outpatient setting.
Significance and Implications for Practice
The project leader anticipated that this project would result in more consistent provider
referrals to the in-house counselor or primary care physician for patients post-MI who screened
positive for depression using the PHQ-9 tool. Even though there was no referral increase, one of
the desired goals was for the cardiology providers to have a better awareness of depression as a
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marker of poor outcomes, specifically an increased risk for further myocardial infarctions,
stroke, transient ischemic attack, heart failure, or death. This project revealed a variety of
opportunities within the outpatient practice to further educate and inform the providers on the
importance of screening for depression, reviewing the PHQ-9 results, and increasing the number
of referrals. These AHA guidelines were recognized and have been established since 2008. The
greatest lessons learned included the need to target provider knowledge, perceptions, and
attitudes regarding the AHA guidelines and the PHQ-9 tool, with an emphasis on identifying at
risk patients for depression, post-MI.
Alternative approaches for future practice improvement revealed the need to target the
nursing population. Nursing staff are responsible for administering the PHQ-9 screening tool for
patients to complete prior to being evaluated by a cardiology provider, on the initial post-MI
follow-up visit, post-hospitalization. The necessity for an improved protocol and process change
has been identified within the outpatient setting among providers, focusing on integrating the
nursing population. It is essential for the nurses to ensure the screening tool is being administered
to all patients post-MI, in addition to alerting providers if an individual scores ten points or
greater on the PHQ-9. This has been acknowledged as one of the contributing factors for patients
not being identified or screened according to the guidelines. Education must be targeted towards
the nursing population in order to develop and to create a better understanding and knowledge
base in regard to the significance of depression associated post-MI, the AHA guidelines, and the
PHQ-9 tool.
As a result of this project’s implementation, it was discovered the project leader delivered
important information and education to the cardiology providers on the significance of screening
for depression and referring appropriately, in an effort to narrow the gap in knowledge,
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ultimately in an attempt to improve outcomes and quality of life in patients post-MI. These
practice implications identified existing gaps of provider perception in regard to the need to
improve interprofessional collaboration, adhere to the AHA guidelines, and cultivate process
changes within the current protocol. Through the use of this chart audit it was discovered that
there was no documentation of screening using the PHQ-9 on 35% of patients in the preintervention and 37% in the post-intervention. Adjustments and strategies must be implemented
with a focus on provider knowledge, perceptions, and attitudes, the need to target the nursing
population, and improved preparation and understanding of this process change based on this
project’s implications to practice.
Dissemination Plan
The findings will be disseminated to the organizations involved in this project with a
lessons learned report through the use of a poster presentation and educational handout
discussing the results of increasing the number of referrals for patients, post-MI who screen
positive for depression. Other anticipated methods to disseminate the findings include a podium
presentation and manuscript publication. Disseminating the findings from this project could
potentially include any of the following methods: academic journals, book chapters, technical
reports, trade magazines, regular newspapers, radio or television interviews, websites,
stakeholders, clinical specialty associations, and professional conferences or meetings (Agency
for Health Care Research and Quality [AHRQ], 2014).
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